Search - tctmd.com

Displaying 281 - 300 of 2514

Sort: Relevancy | Date

News Conference News TCT 2024

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

Todd Neale

October 31, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

Presentation TCT 2024

TCT 867: Vcal+CT: Detect, evaluate and prevent complications by accurately assessing vascular and valvular calcium

Presenter: Victor Alfonso Jimv©nez Dv?az

October 30, 2024

Presentation TCT 2024

TCT 868: Potential Pre-TAVR CT Based Computational Modeling Derived Geometric Predictors of Post-TAVR Leaflet Thrombosis in Self-Expandable Valves

Presenter: Aniket Venkatesh

October 30, 2024

Presentation TCT 2024

TCT 869: Insight From Pre and Post Redo-TAV Computed Tomography Assessment: Implication for Sizing, Positioning and Coronary Risk

Presenter: NULL

October 30, 2024

Presentation TCT 2024

TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

TCT 866: Regional Left Intraventricular Systolic Pressure Gradients (IVPG) in the Nonobstructive Ventricle and Potential Impact on Invasive and Echo Aortic Valve Gradients

Presenter: Safwan Kassas

October 30, 2024

Presentation TCT 2024

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

Presenter: Mahesh Madhavan

October 30, 2024

Presentation TCT 2024

TCT 1592: Management of Post-TAVR Severe PVL: A TAV-in-TAV Case

Presenter: Chloe Kharsa

October 30, 2024

Presentation TCT 2024

Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients

Presenter: Julien Ternacle

October 30, 2024

Presentation TCT 2024

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

Presenter: Philippe Pibarot

October 30, 2024

Presentation TCT 2024

TCT 1359: Management Strategies of Paravalvular Leak in the Post-TAVR Patient: ?To Plug or to Balloon?

Presenter: Mariah Mascara

October 30, 2024

Presentation TCT 2024

Lessons Learned From the SMART Trial

Presenter: Howard Herrmann

October 30, 2024

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

Electrosurgery Leaflet Modification – Technique and Results After BASILICA

Presenter: Jaffar Khan

October 30, 2024

Presentation TCT 2024

Mechanical Leaflet Modification – Technique and Results After SHORTCUT

Presenter: Danny Dvir

October 30, 2024

Presentation TCT 2024

TCT 915: Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial

Presenter: Pieter Smits

October 30, 2024

Presentation TCT 2024

TCT 916: MÉTIS Study: Modification of NEurological Outcome After TAVR UsIng Sentinel Protection Device

Presenter: Tomas Kovarnik

October 30, 2024

Presentation TCT 2024

TCT 919: EasyCross Self-Centering Catheter to Facilitate Aortic Valve Crossing During TAVR: A First in Human Feasibility Trial

Presenter: Marco Ancona

October 30, 2024

Presentation TCT 2024

TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level

Presenter: G. Michael Deeb

October 30, 2024

Advertisement

Embolic Protection Benefits Varied by Geography in PROTECTED TAVR

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

TCT 867: Vcal+CT: Detect, evaluate and prevent complications by accurately assessing vascular and valvular calcium

TCT 868: Potential Pre-TAVR CT Based Computational Modeling Derived Geometric Predictors of Post-TAVR Leaflet Thrombosis in Self-Expandable Valves

TCT 869: Insight From Pre and Post Redo-TAV Computed Tomography Assessment: Implication for Sizing, Positioning and Coronary Risk

TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

TCT 866: Regional Left Intraventricular Systolic Pressure Gradients (IVPG) in the Nonobstructive Ventricle and Potential Impact on Invasive and Echo Aortic Valve Gradients

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

TCT 1592: Management of Post-TAVR Severe PVL: A TAV-in-TAV Case

Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

TCT 1359: Management Strategies of Paravalvular Leak in the Post-TAVR Patient: ?To Plug or to Balloon?

Lessons Learned From the SMART Trial

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Electrosurgery Leaflet Modification – Technique and Results After BASILICA

Mechanical Leaflet Modification – Technique and Results After SHORTCUT

TCT 915: Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial

TCT 916: MÉTIS Study: Modification of NEurological Outcome After TAVR UsIng Sentinel Protection Device

TCT 919: EasyCross Self-Centering Catheter to Facilitate Aortic Valve Crossing During TAVR: A First in Human Feasibility Trial

TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content